Showing results (321-330 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|January 8, 2021
Do epoch lengths of hypnotic depth indicators affect estimated of blood-brain equilibration rate constants of propofol?Kyung Mi Kim, Sookyung Park, Bong Jin Kang, et al.Journal of Pharmacokinetics and Pharmacodynamics|June 22, 2021
Optimal control for colistin dosage selectionAline Vidal Lacerda Gontijo, André V G CavalieriJournal of Pharmacokinetics and Pharmacodynamics|June 19, 2021
Two-pore physiologically based pharmacokinetic model validation using whole-body biodistribution of trastuzumab and different-size fragments in miceZhe Li, Yingyi Li, Hsuan Ping Chang, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 24, 2021
Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 1. THR-149Marc Vanhove, Bernard Noppen, Jean-Marc Wagner, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 24, 2021
Delay differential equations based models in NONMEMXiaoyu Yan, Robert Bauer, Gilbert Koch, et al.Journal of Pharmacokinetics and Pharmacodynamics|April 21, 2023
Operational characteristics of full random effects modelling ('frem') compared to stepwise covariate modelling ('scm')Lisa F Amann, Sebastian G WichaJournal of Pharmacokinetics and Pharmacodynamics|May 2, 2023
The future of rare disease drug development: the rare disease cures accelerator data analytics platform (RDCA-DAP)Jeffrey S Barrett, Alexandre Betourne, Ramona L Walls, et al.Journal of Pharmacokinetics and Pharmacodynamics|December 3, 2003
Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified modelsSven BjörkmanJournal of Pharmacokinetics and Pharmacodynamics|July 7, 2019
FDA's Office of Orphan Products Development: providing incentives to promote the development of products for rare diseasesSoumya Patel, Katherine I Miller NeedlemanJournal of Pharmacokinetics and Pharmacodynamics|September 18, 2016
Assessment of non-linear combination effect terms for drug-drug interactionsGilbert Koch, Johannes Schropp, William J JuskoPageof 107